256 related articles for article (PubMed ID: 11138290)
1. [Combined vaccine against polio, diphtheria and tetanus. Closing vaccination gaps!].
Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies OE; Jilg W
MMW Fortschr Med; 2000 Nov; 142(48):54. PubMed ID: 11138290
[No Abstract] [Full Text] [Related]
2. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
Black S; Greenberg DP
Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
[TBL] [Abstract][Full Text] [Related]
3. [Combined vaccine against tetanus, diphtheria and polio. A randomized controlled study of immunogenicity and tolerance].
Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies OE; Jilg W
Fortschr Med Orig; 2001 Jan; 118(4):169-72. PubMed ID: 11217682
[TBL] [Abstract][Full Text] [Related]
4. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.
Gajdos V; Soubeyrand B; Vidor E; Richard P; Boyer J; Sadorge C; Fiquet A
Hum Vaccin; 2011 May; 7(5):549-56. PubMed ID: 21441781
[TBL] [Abstract][Full Text] [Related]
6. [Study of vaccination for travel shows: serious gaps in polio, diphtheria and tetanus vaccination].
Ludwig B; Doerr HW; Allwinn R
MMW Fortschr Med; 2001 Jul; 143(28-29):29-31. PubMed ID: 11499143
[TBL] [Abstract][Full Text] [Related]
7. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.
Puumalainen T; Dagan R; Wuorimaa T; Zeta-Capeding R; Lucero M; Ollgren J; Käyhty H; Nohynek H
Pediatr Infect Dis J; 2003 Feb; 22(2):141-9. PubMed ID: 12586978
[TBL] [Abstract][Full Text] [Related]
8. Protection against vaccine-preventable diseases in medical students.
Baer G; Bonhoeffer J; Schaad UB; Heininger U
Pediatr Infect Dis J; 2003 Apr; 22(4):373-4. PubMed ID: 12712970
[No Abstract] [Full Text] [Related]
9. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
Gabutti G
J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
[No Abstract] [Full Text] [Related]
10. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.
Nordøy T; Husebekk A; Aaberge IS; Jenum PA; Samdal HH; Flugsrud LB; Kristoffersen AC; Holte H; Kvaløy S; Kolstad A
Bone Marrow Transplant; 2001 Oct; 28(7):681-7. PubMed ID: 11704791
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of anti-polio and anti-HSV IgA pre-plasma cell response in blood following parenteral immunization with tetanus-diphtheria vaccine.
Fernandes JR; Wasserman S; Snider DP
Vaccine; 2010 Feb; 28(6):1493-8. PubMed ID: 20003921
[TBL] [Abstract][Full Text] [Related]
12. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007.
Bitragunta S; Murhekar MV; Chakravarti A; Verma V; Namjoshi GS; Parekh SS; Sharma HJ; Kumar BK; Gupte MD
Vaccine; 2010 Aug; 28(37):5934-8. PubMed ID: 20620169
[TBL] [Abstract][Full Text] [Related]
14. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
15. [Use of combined vaccines in children].
Plebani A
Ann Ig; 2002; 14(4 Suppl 5):85-91. PubMed ID: 12389297
[No Abstract] [Full Text] [Related]
16. Australian childhood immunisation coverage, April to June cohort, assessed as at 30 September 2014.
Hull BP
Commun Dis Intell Q Rep; 2015 Mar; 39(1):E167-8. PubMed ID: 26063091
[No Abstract] [Full Text] [Related]
17. Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2014.
Hull BP
Commun Dis Intell Q Rep; 2015 Mar; 39(1):E165-6. PubMed ID: 26063090
[No Abstract] [Full Text] [Related]
18. [Influence of information campaigns on the vaccination immunity among the population of a small town area - seroepidemiological results of the 'Wittlich Vaccination Study'].
Pietsch M; Michels H; Diwo J; Martens H; Jacob R; Lossen-Geissler E; Bussmann H
Gesundheitswesen; 2002 Jan; 64(1):60-4. PubMed ID: 11791204
[TBL] [Abstract][Full Text] [Related]
19. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
20. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
Olin P
Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
